S. 1822 (119th)Bill Overview

SAFE FOOD Act of 2025

Agriculture and Food|Agriculture and Food
Cosponsors
Support
Republican
Introduced
May 20, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Agriculture, Nutrition, and Forestry.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

Requires the Secretary of Agriculture to study consolidating federal food-safety responsibilities (including FSIS, FDA, CDC roles) into a single agency. The study must begin within 60 days of enactment and a report with findings and recommendations is due to relevant congressional committees within one year.

Why people may split

Progressives stress public-health safeguards and risk of industry capture

Watch point

Relative to its intended legislative type, this bill is a straightforward, time‑bounded study/report mandate that identifies the responsible official and deadlines but provides limited guidance on methodology, content, resourcing, legal integration, risk assessment, or oversight beyond submission of a single report.

Requires the Secretary of Agriculture to study consolidating federal food-safety responsibilities (including FSIS, FDA, CDC roles) into a single agency.

The study must begin within 60 days of enactment and a report with findings and recommendations is due to relevant congressional committees within one year.

Passage35/100

Low substantive impact makes passage plausible, but many narrowly targeted study bills fail to advance beyond committee without broader support or appropriation.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a straightforward, time‑bounded study/report mandate that identifies the responsible official and deadlines but provides limited guidance on methodology, content, resourcing, legal integration, risk assessment, or oversight beyond submission of a single report.

Contention45/100

Progressives stress public-health safeguards and risk of industry capture

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitCould identify efficiencies and reduce duplicated inspection and regulatory activities across agencies.
  • Potential benefitMay recommend unified regulatory standards that simplify compliance for food producers and processors.
  • Potential benefitPotential for faster outbreak response through centralized coordination and unified information sharing.
Likely burdened
  • Potential burdenStudy and eventual consolidation could disrupt ongoing public health programs during transition periods.
  • Potential burdenMerging agencies may generate substantial upfront restructuring, legal, and administrative costs.
  • Federal agenciesConsolidation risks loss of specialized scientific expertise tailored to distinct agency missions.
03 · Why people split

Why the argument around this bill splits.

Progressives stress public-health safeguards and risk of industry capture
Progressive45%

Cautious about consolidation but open to evidence-based improvement.

Concerned consolidation under USDA could prioritize industry interests over consumer health.

Because this bill only mandates a study, the persona would condition support on strong safeguards and public-health independence.

Split reaction
Centrist75%

Sees this as a pragmatic, limited step to evaluate potential efficiencies.

Favors an evidence-based study to identify duplication and clarify responsibilities.

Will weigh benefits against transition costs and legal complexities before supporting structural change.

Leans supportive
Conservative70%

Generally favorable to streamlining and reducing duplicative bureaucracy, seeing consolidation as a way to improve regulatory clarity.

However, cautious about creating a larger centralized agency that could expand regulatory reach.

Views the mandated study as a reasonable first step.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood35/100

Low substantive impact makes passage plausible, but many narrowly targeted study bills fail to advance beyond committee without broader support or appropriation.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No appropriation or cost estimate included
  • Possible jurisdictional objections from HHS/other agencies
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives stress public-health safeguards and risk of industry capture

Low substantive impact makes passage plausible, but many narrowly targeted study bills fail to advance beyond committee without broader sup…

Unlocked analysis

Relative to its intended legislative type, this bill is a straightforward, time‑bounded study/report mandate that identifies the responsible official and deadlines but provides limited guidance on methodology, content,…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis